. 2011 Dec 9;44(3):761–767. doi: 10.1007/s11255-011-0102-z

Table 2.

Percent of positive qRT-PCR signal for EGFR, COL1A1 and COL3A1 mRNAs and relative expression levels of KIT and CD47 in blood samples collected from controls and patients treated for bladder tumors

	Controls	Days after TURBT (P values)
Positive signal of expression (percent)
EGFR	0%	27% (0.0006)	20% (0.005)	14% N.S.	10% N.S.	4% N.S.
COL1A1	3%	27% (0.007)	45% (0.0004)	25% (0.007)	36% (0.0004)	23% N.S.
COL3A1	28%	40% N.S.	38% N.S.	30% N.S.	36% N.S.	22% N.S.
Relative expression levels
KIT	0.061†	0.231 (8.66E−07)	0.265 (0.003)	0.224 (1.43E−06)	0.258 (1.70E−06)	0.291 (1.23E−06)
CD47	0.020	0.279 (2.71E−08)	0.233 (1.09E−08)	0.264 (1.30E−07)	0.219 (1.10E−08)	0.200 (8.46E−08)

Controls

Days after TURBT (P values)

Before

Positive signal of expression (percent)

EGFR

27%

(0.0006)

20%

(0.005)

14%

N.S.

10%

N.S.

COL1A1

27%

(0.007)

45%

(0.0004)

25%

(0.007)

36%

(0.0004)

23%

N.S.

COL3A1

28%

40%

N.S.

38%

N.S.

30%

N.S.

36%

N.S.

22%

N.S.

Relative expression levels

KIT

0.061†

0.231

(8.66E−07)

0.265

(0.003)

0.224

(1.43E−06)

0.258

(1.70E−06)

0.291

(1.23E−06)

CD47

0.020

0.279

(2.71E−08)

0.233

(1.09E−08)

0.264

(1.30E−07)

0.219

(1.10E−08)

0.200

(8.46E−08)

† Control group consisted of 17 healthy volunteers selected from laboratory staff